R
Robert F. Todd
Researcher at University of Michigan
Publications - 100
Citations - 7238
Robert F. Todd is an academic researcher from University of Michigan. The author has contributed to research in topics: Receptor & Antigen. The author has an hindex of 44, co-authored 99 publications receiving 7127 citations. Previous affiliations of Robert F. Todd include University of Pennsylvania & Monsanto.
Papers
More filters
Journal ArticleDOI
Regulation of transendothelial neutrophil migration by endogenous interleukin-8
TL;DR: Endothelial cell production of a 77-amino acid variant of interleukin-8 (IL-8) was found to be a requirement for the invasion of neutrophils through a vessel wall model and regulates transvenular traffic during acute inflammatory responses.
Journal ArticleDOI
Immunologic classification of leukemia and lymphoma.
Kenneth A. Foon,Robert F. Todd +1 more
TL;DR: It is now clear that acute lymphoblastic leukemia (ALL) is heterogeneous and monoclonal antibodies that identify B cells, such as the anti-B1 andAnti-B4 antibodies in combination with studies of immunoglobulin gene rearrangement, have demonstrated that virtually all cases of non-T-ALL are malignancies of B cell origin.
Journal ArticleDOI
The urokinase receptor is required for human monocyte chemotaxis in vitro.
TL;DR: It is demonstrated that expression and unimpeded function of uPAR plays an obligate role in M phi chemotaxis by mechanisms that are largely independent of its ligand, uPA.
Journal Article
Urokinase-Type Plasminogen Activator Receptors Associate with β1 and β3 Integrins of Fibrosarcoma Cells: Dependence on Extracellular Matrix Components
TL;DR: In this paper, the effect of saccharides on the β1 and β3 integrin-uPAR colocalization and RET was investigated. But the results showed that β1 integrin colocalisation and RET were effectively inhibited by N -acetyl-d-glucosamine on extracellular matrix-coated surfaces.
Journal ArticleDOI
Anti‐CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat
Hua Chen,Michael Chopp,Michael Chopp,Ruilan Zhang,G. Bodzin,Q. Chen,Q. Chen,James R. Rusche,Robert F. Todd +8 more
TL;DR: The data demonstrate that administration of anti‐CD11b antibody results in a dose‐dependent, significant functional improvement and reduction of ischemic cell damage after transient focal cerebral ischemia in the rat.